Köpenysejtes limfóma: vizsgálatok itt: Svédország
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleCAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
- Where
- Huddinge, Uppsala
- Életkor
- 18 év and over
- People
- 18
- Run by
- Uppsala University
See details and how to joinNCT06002659 · EU 2024-511844-18-00 - 3. fázisTaking peopleA Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Where
- Lund, Uppsala
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06084936 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Gothenburg, Stockholm
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - 2. fázisTaking peoplePIRTOBRUTINIB AND GLOFITAMAB IN MANTLE CELL LYMPHOMA
- Where
- Linkoping, Lund, Solna, Umea, Uppsala
- Életkor
- 18 év and over
- People
- 96 worldwide
- Run by
- Klinikum der Universitaet Muenchen AöR
See details and how to join2024-512922-27-00 · EU 2024-512922-27-00 - 3. fázisTaking peopleA Study to Compare the Efficacy and Safety of Glofitamab as a Single Agent Versus Investigator’s Choice in Patients with Relapsed/Refractory Mantle Cell Lymphoma
- Where
- Lund, Uppsala
- Életkor
- 18 év and over
- People
- 39 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-503206-37-00 · EU 2023-503206-37-00